Australia markets closed

Jazz Pharmaceuticals plc (J7Z.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
99.58+0.06 (+0.06%)
At close: 05:15PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 6.29B
Enterprise value 9.99B
Trailing P/E 22.08
Forward P/E 5.42
PEG ratio (5-yr expected) 0.76
Price/sales (ttm)1.92
Price/book (mrq)1.82
Enterprise value/revenue 2.78
Enterprise value/EBITDA 9.16

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-12.15%
S&P500 52-week change 322.55%
52-week high 3134.35
52-week low 395.18
50-day moving average 3100.92
200-day moving average 3110.42

Share statistics

Avg vol (3-month) 326
Avg vol (10-day) 324
Shares outstanding 563.06M
Implied shares outstanding 663.12M
Float 861.25M
% held by insiders 12.78%
% held by institutions 196.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.61%
Operating margin (ttm)11.66%

Management effectiveness

Return on assets (ttm)4.07%
Return on equity (ttm)9.41%

Income statement

Revenue (ttm)3.84B
Revenue per share (ttm)60.96
Quarterly revenue growth (yoy)1.00%
Gross profit (ttm)N/A
EBITDA 1.37B
Net income avi to common (ttm)330.79M
Diluted EPS (ttm)4.51
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.82B
Total cash per share (mrq)28.92
Total debt (mrq)5.79B
Total debt/equity (mrq)156.50%
Current ratio (mrq)2.27
Book value per share (mrq)58.65

Cash flow statement

Operating cash flow (ttm)1.04B
Levered free cash flow (ttm)1.04B